CoChat

Gastrointestinal surgery and gut hormones

Aylwin, Simon · 2005 · Current Opinion in Endocrinology & Diabetes
Cited by 28

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Purpose of review Surgical treatment of obesity remains by far the most effective means of achieving weight loss, and in addition leads to normalised glucose tolerance in patients with type 2 diabetes mellitus (T2DM). Bariatric surgical procedures have recently been shown to effect changes in the secretion of gastro-intestinal hormones involved in energy regulation and intermediary metabolism that may contribute to appetite reduction, weight loss and remission of T2DM. Recent findings Ghrelin is released from the stomach in the pre-prandial state and stimulates food intake. Weight loss through dietary restraint elevates the low circulating levels of ghrelin in obese subjects, but following Roux-en-Y gastric bypass surgery (RYGB), obese subjects were shown to have suppressed levels of ghrelin. Subsequent prospective studies, however, have found inconsistent ghrelin responses following RYGB. Peptide YY (PYY) is expressed in the ileum, released in response to the ingestion of food and acts centrally to inhibit food intake. Recent studies have shown that PYY levels are reduced in obesity although obese subjects remain sensitive to exogenous PYY. Following RYGB, PYY release is exaggerated, an effect that should inhibit subsequent meal size. Glucagon-like peptide 1 (GLP-1), released from the same cells as PYY, shows a pronounced post-prandial elevation after RYGB that may be responsible for an enhanced early insulin release and contribute to the normalisation of glucose homeostasis. Summary The pleiotropic endocrine effects of RYGB that favor weight loss present strong circumstantial evidence for a humoral effect of RYGB on appetite and food intake. Mimicking the effects of RYGB on the entero-hypothalamic axis has become an attractive goal for pharmacotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.med.0000152979.05456.b6

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 28

Metadata

Authors
Aylwin, S.
Venue
Current Opinion in Endocrinology & Diabetes
Published
2005-02
Volume
12
Issue
1
Pages
89-98
ISSN
1068-3097 (ISSN-L)
OpenAlex
W1975150741
Cited by
28
References
13
FWCI
4.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastrointestinal surgery and gut hormones. https://app.cochat.ai/papers/10.1097/01.med.0000152979.05456.b6
The paper
Aylwin, S. (2005). Gastrointestinal surgery and gut hormones. Current Opinion in Endocrinology & Diabetes. https://doi.org/10.1097/01.med.0000152979.05456.b6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.